AstraZeneca 거래 AZN

AstraZeneca 실시간 차트

상품 기초

Weekly Search
Weekly
Daily
날짜 종료 변경 변동(%) 열기 높음 낮음

AstraZeneca news

Frances Wang 2025 Jun 02, 16:00

TEM stock price analysis: Why Tempus AI Stock Up Today?

Stocks
London Uk
Georgy Istigechev 2024 Jan 16, 08:02

FTSE 100 index near one-month lows as global sentiment sours

Shares Indices FTSE100
Moderna Share Price
Georgy Istigechev 2024 Jan 03, 08:01

Moderna share price jumps as Oppenheimer upgrades stock

Shares
Consumer inflation
Neil Wilson 2023 Nov 03, 04:01

Week ahead: RBA poised to hike?

Forex Indices
FTSE 100
Georgy Istigechev 2023 Sep 26, 10:00

FTSE 100 Index: London stocks start week sharply lower

Indices

최신 뉴스

더 보기
Emma Rose 2025 Jul 24, 13:20

ECB Holds Rates Steady Amid Trade Uncertainty

Sophia Claire 2025 Jul 24, 10:20

Senator Scott Demands Answers on Federal Reserve's Contentious Renovation Project

Liam James 2025 Jul 24, 09:20

Obama Admin Allegations of Falsifying Intel on Trump-Russia Interference

Liam James 2025 Jul 24, 08:20

Dubai Gold Market Surges: Solidifying its Position as a Key Global Asset

Liam James 2025 Jul 24, 06:20

Trump vs. Powell: Will the Fed Chair Stay or Go?

Noah Lee 2025 Jul 24, 06:20

ECB Rate Decision: Navigating Tariffs, Inflation, and Economic Uncertainty

Noah Lee 2025 Jul 24, 04:20

Trump's Japan Trade Deal: Discrepancies and Investment Uncertainties

Liam James 2025 Jul 24, 03:20

Tesla's Challenges Deepen: Q2 Earnings Decline and Future Outlook

정보

스프레드

67.48

스프레드(%)

0.6203 %

레버리지

1:10

익일 이자 매수

-0.0590 %

익일 이자 매도

-0.0299 %

통화

PNC

거래 시간

시장 폐장

금요일

07:01 - 10:59

월요일

07:01-10:59

월요일

11:03-15:29

화요일

07:01-10:59

화요일

11:03-15:29

수요일

07:01-10:59

수요일

11:03-15:29

목요일

07:01-10:59

목요일

11:03-15:29

분석 및 통계

열기

---

이전 종가

---

52주 최고/최저

--- – ---

시가총액

165471551488

발행 주식 수

1550230016

수익 날짜 (다음)

0000-00-00

배당수익률

배당락일

2025-02-20

예상 연간 배당금

2.46

예상 연간 배당수익률

0.0237

EPS

3.69

이 상품에 대해 자세히 알아보기

AstraZeneca AstraZeneca PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, Byetta, XIGDUO, Accolate, Accoleit, Vanticon, Beyfortus, Synagis, FluMist, tixagevimab and cilgavimab, and sipavibart. It also provides Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Bricanyl Turbuhaler, Rhinocort, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Breztri Aerosphere, Duaklir Genuair, Kavigale, Evusheld, Fluenz/FluMist, and Voydeya. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the United States, Europe, and Asia. It has a strategic agreement with Tempus to develop the largest multimodal foundation model in oncology. The company has a collaboration agreement with IonQ, Inc. for the development of quantum-accelerated computational chemistry workflow for healthcare, life sciences, and chemistry; and a strategic research collaboration with CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications. AstraZeneca PLC was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

latest_education_articles

더 보기
Trustpilot